Chemotherapy of non-small cell lung carcinoma guided by an in vitro drug resistance assay measuring total tumour cell kill

British Journal of Cancer

Volumn 65, Issue 1, 1992, Pages 27-32

  Wilbur, D W ^a,b   Camacho, E S ^a,b   Hilliard, D A ^a   Dill, P L ^c   Weisenthal, L M ^d  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; LOMUSTINE; MITOMYCIN C; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER SURVIVAL; CELL KILLING; CHEMOSENSITIVITY; CLINICAL ARTICLE; DRUG CHOICE; DRUG RESISTANCE; DRUG RESPONSE; DRUG SCREENING; HEMATOLOGIC DISEASE; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALAISE; METHODOLOGY; NAUSEA; PATIENT CODING; PERFORMANCE; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; TUMOR CELL; TUMOR CELL DESTRUCTION;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; ETOPOSIDE; FOLLOW-UP STUDIES; HUMAN; LUNG NEOPLASMS; MIDDLE AGE; PROGNOSIS; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0026565780     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1992.5     Document Type: Article

References (45)

1. BEKSAC, M., KANSU, E., KARS, A., IBRAHIMOGLU, Z. & FIRAT, D. (1988). A rapid drug sensitivity assay for neoplasmatic cells. Med. Oncol. Tumor. Pharmacother., 5, 253.
2. BERGER, N. A. (1985). Poly-(ADP-ribose) in the cellular response to DNA damage. Radiat. Res., 101, 4.
3. BIRD, M. C., BOSANQUET, A. G. & GILBY, E. D. (1985) In vitro determination of tumour chemosensitivity in haematological malignancies. Hematol. Oncol., 3, 1.
4. BIRD, M. C., BOSANQUET, A. G., FORSKITT, S. & GILBY, E. D. (1986). Semi-micro adaptation of a 4-day differential staining cytotoxicity (DiSC) assay for determining the in vitro chemosensitivity of haematological malignancies. Leuk. Res., 10, 445.
5. BOSANQUET, A. G. (1991). Clinical correlations of an in vitro cytotoxicity assay in human leukemia. Lancet, 337, 711.
6. BOSANQUET, A. G., BIRD, M. C., PRICE, W. J. & GILBY, E. D. (1983). An assessment of a short-term tumour chemosensitivity assay in chronic lymphocytic leukaemia. Br. J. Cancer, 47, 781.
7. CAMPLING, B. G., PYM, J., GALBRAITH, P R. & COLES, S. P. (1988). Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blastr cells. Leuk. Res., 12, 823.
8. CARSON, D. A., SETO, S., WASSON, D. B. & CARRERA, C. J. (1986). DNA strand breaks, NAD metabolism and programmed cell death. Exp. Cell Res., 164, 273.
9. DIXON, W. J., BROWN, M B., ENGELMAN, L. & 4 others (1985). BMDP Statistical Software Manual. Berkeley, CA: University of California Press, pp. 555-594.
10. GANZ, P. A., FIGLIN, R. A., HASKELL, C. M. & 2 others (1989). Supportive care vs. supportive care and combination chemotherapy in advanced metastatic non-small cell lung cancer: dose chemotherapy make a difference? Cancer, 63, 1271.
11. GAZDAR, A. F., STEINBERG, S. M., RUSSELL, E. K. & 7 others (1990). Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: a prospective clinical trial. J. Natl Cancer Inst., 82, 117.
12. GRAZIANO, S. L., MAZID, R., NEWMAN, N. & 6 others (1989). The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small cell lung cancer. J. Clin. Oncol., 7, 1398.
13. GROUP FOR SENSITIVITY TESTING OF TUMORS (KSST) (1981). In vitro short term test to determine the resistance of human tumors to chemotherapy. Cancer, 48, 2127.
14. HANAUSKE, A. R., HANAUSKE, U. & VON HOFF, D. D. (1987). Recent improvements in the human tumor cloning assay for sensitivity testing of antineoplastic agents. Eur. J. Cancer Clin. Oncol., 23, 603.
15. HANAUSKE, A. R. & von HOFF, D. D. (1986). The value of the human tumor cloning assay in ovarian cancer. Clin. Obstet. Gynecol., 29, 638.
16. HANSEN, H. (1987). Advanced non-small cell lung cancer: to treat or not to treat? J. Clin. Oncol., 5, 1711.
17. KERN, D. H. & WEISENTHAL, L. M. (1990). Highly-specific prediction of antineoplastic drug resistance with an in vitro assay utilizing suprapharmacologic drug concentrations. J. Natl Cancer Inst., 82, 582.
18. KIRKPATRICK, D. L., DUKE, M. & GOH, T. S. (1990). Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. Leuk. Res., 14, 459.
19. LAI, S., GOLDSTEIN, L., GOTTESMAN, M. & 6 others (1989). Relatively low expression of the multidrug resistance associated MDR1 gene occurs in most lung cancer tumors and cell lines. Proc. Am. Soc. Clin. Oncol., 8, 228 (Abstract).
20. LATHAN, B., VON TETTAU, M., VERPOORT, K. & DIEHL, V. (1990). Pretherapeutic drug testing in acute leukemias for prediction of individual prognosis. Haematol. Blood Transfus., 33, 295.
21. LINK, K. H., AIGNER, K. R., KUEHN, W., SCHWEMMLE, K. & KERN, D. H. (1986). Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases. Cancer Res., 46, 4837.
22. LUEDKE, D. W., SARMA, P. R., GRECO, F. A. & 2 others (1987). Preliminary report of a randomized trial of vindesine vs vindesine with mitomycin-c or cisplatin in NSCLC. Proc. Am. Soc. Clin. Oncol., 6, 170 (Abstract).
23. MATTHEWS, D. E. & FAREWELL, V. T. (1988). Using and Understanding Medical Statistics. Basel, Switzerland: Karger. pp. 20-38.
24. MERKEL, D. E., FUQUA, A. W., HILL, S. M. & MCGUIRE, W. L. (1988). P-glycoprotein gene amplification or overexpression is not detected in clinical breast cancer specimens. In Prediction of Response to Cancer Chemotherapy. Prog. Clin. Biol. Res., 276. Hall, T. C. (ed.), pp. 61-74, Alan R. Liss Inc: New York.
25. MULSHINE, J. L., GLATSTEIN, E. & RUCKDESCHEL, J. C. (1986). Treatment of non-small cell lung cancer. J. Clin. Oncol., 4, 1704.
26. RAPP, E., PATER, J. L., WILLAN, A. & 12 others (1988). Chemotherapy can prolong survival in patients with advanced nonsmall-cell lung cancer - report of a Canadian multicenter randomized trial. J. Clin. Oncol., 6, 633.
27. ROTMAN, B., TEPLITZ, C., DICKINSON, K. & COZZOLINO, J. P. (1988). Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting. In Vitro Cell. Dev. Biol., 24, 1137.
28. SALMON, S. E. (1987). Improved methodology for chemosensitivity testing? [editorial]. J. Clin. Oncol., 5, 1861.
29. SCHEITHAUER, W., MOYER, M. P., CLARK, G. M. & VON HOFF, D. D. (1988) Application of a new preclinical drug screening system for cancer of the large bowel. Cancer Chemother. Pharmacol., 21, 31.
30. SONDAK, V. K., BERTELSEN, C. A., KERN, D. H. & MORTON, D. L. (1985). Evolution and clinical application of a rapid chemosensitivity assay. Cancer, 55, 1367.
31. TIDEFELT, U., SUNDMAN-ENGBERG, B., RHEDIN, A. S. & PAUL, C.(1989) In vitro drug testing in patients with acute leukemia with incubations mimicking in vivo intracellular drug concentrations. Eur. J. Haematol., 43, 374.
32. VON HOFF, D. D. (1987). In vitro predictive testing: the sulfonamide era. Int. J. Cell. Cloning, 5, 179.
33. VON HOFF, D. D., CASPER, J., BRADLEY, E., SANDBACH, J., JONES, D. & MAKUCH, R. (1981). Association between human tumor colony-forming assay results and response to an individual patient’s tumor chemotherapy. Am. J. Med., 70, 1027.
34. WEISENTHAL, L. M. (1987). Clones, dyes, nuclides, mouse kidneys, and… virions: a new-clonogenic assay for tumor chemosensitivity. Eur. J. Cancer Clin. Oncol., 23, 9.
35. WEISENTHAL, L. M. (1991). Drug and radiation resistance testing. In Human Cancer in Primary Culture: A Handbook. Masters, J. M. (ed.), Kluwer Academic Publishers: Dordrecht, The Netherlands. Chapter 5, pp. 103-148.
36. WEISENTHAL, L. M., DILL, P. L., KURNICK, N. B. & LIPPMAN, M. E. (1983). Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res., 43, 258.
37. WEISENTHAL, L. M., DILL, P. L., FINKLESTEIN, J. Z., DUARTE, T. E., BAKER, J. A. & MORAN, E. M. (1986). Laboratory detection of primary and acquired drug resistance in human lymphatic neoplasms. Cancer Treat. Rep., 70, 1283.
38. WEISENTHAL, L. M. & KERN, D. H. (1991). Prediction of drug resistance in cancer chemotherapy. Oncol. (USA) (in press, September 1991).
39. WEISENTHAL, L. M., LALUDE, A. O. & MILLER, J. B. (1983). In vitro chemosensitivity of human bladder cancer. Cancer, 51, 1490.
40. WEISENTHAL, L. M. & LIPPMAN, M. E. (1985). Clonogenic and non- clonogenic in vitro chemosensitivity assays. Cancer Treat. Rep., 69, 615.
41. WEISENTHAL, L. M., MARSDEN, J. A., DILL, P. L. & MACALUSO, C. K. (1983). A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res., 43, 749.
42. WEISENTHAL, L. M., NAGOURNEY, R. A. & KERN, D. H. (1990). Extreme drug resistance (EDR) can be accurately detected in fresh specimens of human breast cancer and has implications for adjuvant chemotherapy. In Adjuvant Therapy of Cancer VI. 6th Ed. Salmon, S. E. (ed.) W. B. Saunders Company: Philadelphia, pp. 339-348.
43. WEISENTHAL, L. M., SHOEMAKER, R. H., MARSDEN, J. A., DILL, P. L., BAKER, J. A. & MORAN, E. M. (1984). In vitro chemosensitivity assay based on the concept of total tumor cell kill. Recent Results Cancer Res., 94, 161.
44. WEISENTHAL, L. M., SU, Y. Z., DUARTE, T. E. & NAGOURNEY, R. A. (1988). Non-clonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy. Prog. Clin. Biol. Res., 276, 75.
45. WOODS, R. L., WILLIAMS, C. J., LEVI, J., PAGE, J. & 3 others (1990). A randomised trial of cisplatin and vindosine versus supportive care only in advanced non-small cell lung cancer. Br. J. Cancer, 61, 608.